| Literature DB >> 34706228 |
Margaret H Chang1, Anaïs Levescot2, Nathan Nelson-Maney2, Rachel B Blaustein2, Kellen D Winden3, Allyn Morris2, Alexandra Wactor2, Spoorthi Balu2, Ricardo Grieshaber-Bouyer2, Kevin Wei2, Lauren A Henderson1, Yoichiro Iwakura4, Rachael A Clark5, Deepak A Rao2, Robert C Fuhlbrigge6, Peter A Nigrovic7.
Abstract
Rheumatoid arthritis is a systemic autoimmune disease, but disease flares typically affect only a subset of joints, distributed in a distinctive pattern for each patient. Pursuing this intriguing pattern, we show that arthritis recurrence is mediated by long-lived synovial resident memory T cells (TRM). In three murine models, CD8+ cells bearing TRM markers remain in previously inflamed joints during remission. These cells are bona fide TRM, exhibiting a failure to migrate between joints, preferential uptake of fatty acids, and long-term residency. Disease flares result from TRM activation by antigen, leading to CCL5-mediated recruitment of circulating effector cells. Correspondingly, TRM depletion ameliorates recurrence in a site-specific manner. Human rheumatoid arthritis joint tissues contain a comparable CD8+-predominant TRM population, which is most evident in late-stage leukocyte-poor synovium, exhibiting limited T cell receptor diversity and a pro-inflammatory transcriptomic signature. Together, these findings establish synovial TRM as a targetable mediator of disease chronicity in autoimmune arthritis.Entities:
Keywords: CCL5; CD8; IL-1 receptor antagonist; arthritis flares; cell recruitment; methylated bovine serum albumin; ovalbumin; resident memory T cells; rheumatoid arthritis; synovium
Mesh:
Year: 2021 PMID: 34706228 PMCID: PMC8561718 DOI: 10.1016/j.celrep.2021.109902
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423